Biora Therapeutics Inc (BIOR)
0.73
-0.01
(-0.99%)
USD |
NASDAQ |
May 17, 16:00
0.73
0.00 (0.00%)
After-Hours: 20:00
Biora Therapeutics Total Liabilities (Quarterly): 132.64M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 132.64M |
| September 30, 2023 | 153.49M |
| June 30, 2023 | 170.55M |
| March 31, 2023 | 158.24M |
| December 31, 2022 | 155.81M |
| September 30, 2022 | 160.06M |
| June 30, 2022 | 173.21M |
| March 31, 2022 | 179.92M |
| December 31, 2021 | 193.82M |
| Date | Value |
|---|---|
| September 30, 2021 | 274.65M |
| June 30, 2021 | 259.56M |
| March 31, 2021 | 254.08M |
| December 31, 2020 | 261.43M |
| September 30, 2020 | 180.04M |
| June 30, 2020 | 203.58M |
| March 31, 2020 | 195.74M |
| December 31, 2019 | 185.60M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
132.64M
Minimum
Dec 2023
274.65M
Maximum
Sep 2021
193.67M
Average
180.04M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| Eiger BioPharmaceuticals Inc | 53.28M |
| Disc Medicine Inc | 16.11M |
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 31.22M |
| Shareholders Equity (Quarterly) | -101.42M |